gilteritinib
astellas pharmaceuticals
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'gilteritinib']
#eha22 #leusm craddock: allohct essentially important in flt3-itd+ aml, even in patients of advanced age. post-allo maintenance to buy time for gvl effect should be standard of care based on available data (while awaiting data from 1506 gilteritinib rct). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)